Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Ferguson (FERG) by Royston Wild in The Motley Fool
- Buy Royal Bank of Scotland Group (RBS) by Peter Stephens in The Motley Fool
- Buy Rightmove (RMV) by Peter Stephens in The Motley Fool
- Avoid Restaurant Group (RTN) by Royston Wild in The Motley Fool
- Long Term Buy TBC Bank Group (TBCG) by Royston Wild in The Motley Fool
- Avoid Dixons Carphone (DC.) by Royston Wild in The Motley Fool
- Buy City of London Investment Group (CLIG) by Kevin Godbold in The Motley Fool
- Sell Burford Capital (BUR) by Rupert Hargreaves in The Motley Fool
- Long Term Buy Barclays (BARC) by Roland Head in The Motley Fool
- Buy Chesnara (CSN) by Analyst Team (The Share Centre) in The Share Centre
- Long Term Buy Centamin (DI) (CEY) by Royston Wild in The Motley Fool
- Buy GlaxoSmithKline (GSK) by Paul Summers in The Motley Fool
- Buy Biffa (BIFF) by Paul Summers in The Motley Fool
- Buy B&M European Value Retail S.A. (DI) (BME) by Paul Summers in The Motley Fool
- Speculative Buy Bushveld Minerals Limited (BMN) by Roland Head in The Motley Fool
- Avoid Imperial Brands (IMB) by Rupert Hargreaves in The Motley Fool
- Buy Bloomsbury Publishing (BMY) by Royston Wild in The Motley Fool
- Buy Target Healthcare Reit Ltd (THRL) by Royston Wild in The Motley Fool
- Avoid Lloyds Banking Group (LLOY) by Kevin Godbold in The Motley Fool
- Avoid British American Tobacco (BATS) by Rupert Hargreaves in The Motley Fool
GlaxoSmithKline (GSK)
Health Care Sector
-
Latest quote
1,627.20p (mid)
-
Current Change (%)
-0.51%
-
Price
Bid: 1,631.60p
Offer: 1,631.80p
-
Today
High: 1,642.40p
Low: 1,622.40p
-
This year
High: 1,745.20p
Low: 1,418.00p
-
Information
Volume: 3,257,515
Market Cap: £81164.74M
GlaxoSmithKline Overview
UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.GlaxoSmithKline RNS Feed
| Title | Release date |
|---|---|
| Director/PDMR Shareholding | 16:30 - September 11, 2019 |
| Director/PDMR Shareholding | 17:37 - September 4, 2019 |
| Director/PDMR Shareholding | 12:36 - September 4, 2019 |
| Director/PDMR Shareholding | 09:33 - September 4, 2019 |
| Total Voting Rights | 11:29 - September 2, 2019 |
| GSK - positive results from pivotal DREAMM-2 study | 07:00 - August 23, 2019 |
| ViiV results positive for every 2 month injection | 07:00 - August 22, 2019 |
| GSK submits regulatory file in Japan: Daprodustat | 08:00 - August 21, 2019 |
| Director/PDMR Shareholding | 15:45 - August 12, 2019 |
| EU approval for Nucala self-administration | 15:30 - August 1, 2019 |
| Total Voting Rights | 14:10 - August 1, 2019 |
| Director/PDMR Shareholding | 15:35 - July 30, 2019 |
| ViiV submits cabotegravir to EMA for HIV injection | 07:00 - July 29, 2019 |
| Director/PDMR Shareholding | 18:01 - July 24, 2019 |
| ViiV 2DR TANGO switch study positive at 48 weeks | 16:01 - July 24, 2019 |
NOTE: This is based on 254 open tips for this company
